Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

AstraZeneca PLC (AZN) had Revenue of $15.29B for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$15.29B
Net Income	$3.08B
Cost of Goods Sold	$2.68B
Gross Profit	$12.61B
Operating Expenses	$11.04B
Operating Income	$4.25B
Non-Operating Income/Expense	$-332.00M
Pre-Tax Income	$3.91B
Normalized Pre-Tax Income	$3.91B
Income after Taxes	$3.08B
Income from Continuous Operations	$3.08B
Consolidated Net Income/Loss	$3.08B
Normalized Income after Taxes	$3.08B
EBIT	$4.25B
EBITDA	$5.61B
Weighted-Average Shares Outstanding (Basic)	1.55B
Weighted-Average Shares Outstanding (Diluted)	1.56B
Earnings per Share (EPS) (Basic)	$1.99
Earnings per Share (EPS) (Diluted)	$1.97
Balance Sheet Financials
Current Assets	$29.61B
Property, Plant, and Equipment	$13.12B
Long-Term Assets	$84.40B
Total Assets	$114.02B
Current Liabilities	$32.57B
Long-Term Debt	$24.45B
Long-Term Liabilities	$34.06B
Total Liabilities	$66.63B
Common Equity	$47.38B
Tangible Shareholders Equity	$-10.72B
Shareholders Equity	$47.38B
Common Shares Outstanding	1.55B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$3.36B
Cash Flow from Investing Activities	$-1.79B
Cash Flow from Financial Activities	$267.00M
Beginning Cash	$5.70B
End Cash	$7.51B
Increase/Decrease in Cash	$1.82B
Stock-Based Compensation	--
Common Stock Dividends Paid	$-3.29B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.91
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.34
Debt to Equity Ratio	0.68
Gross Margin	82.48%
Operating Margin	27.77%
EBIT Margin	27.77%
EBITDA Margin	--
Pre-Tax Profit Margin	25.60%
Profit Margin	20.15%
Free Cash Flow	$2.82B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.13
Inventory Turnover	0.41
Receiveable Turnover	1.01
Days Sales in Receivables	89.28
Return on Equity	6.50%
Return on Tangible Equity	-28.75%
Return on Assets	2.70%
Return on Investments	4.29%
Book Value Per Share	$30.59
Free Cash Flow per Share	$1.81
Operating Cash Flow per Share	$2.15

Data from Zacks Investment Research, Inc.